(Q42524659)

English

De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alexander Khoruts

4

object named as

Alexander Khoruts

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Johnthomas Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Stephen J Huddleston

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Joanne M Fraser

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

12 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Journal of Leukocyte Biology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1230-1239

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Developmental regulation of Foxp3 expression during ontogeny.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

In vivo instruction of suppressor commitment in naive T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Inflammatory bowel disease: clinical aspects and established and evolving therapies

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

mTOR at the crossroads of T cell proliferation and tolerance

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Determination of lymphocyte division by flow cytometry

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Foxp3 in control of the regulatory T cell lineage

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Immune mechanisms of allergen-specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

TOR signaling in growth and metabolism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Regulation of translation initiation by FRAP/mTOR

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

The Pim kinases control rapamycin-resistant T cell survival and activation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Predicted mechanisms of resistance to mTOR inhibitors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1207851

21 January 2018

Identifiers

10.1189/JLB.1207851

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42524659&oldid=1574215448"